Description
Febuxostat 80 (brand name Febulas) is a medication used to manage chronic hyperuricemia in patients with gout by reducing uric acid production. It is an alternative to allopurinol, especially for patients with kidney impairment or those who experience allopurinol-related side effects.
INDICATION
Febuxostat (Febulas) is a FDA Approved xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in patients with gout, Febuxostat (Febulas) is not recommended for the treatment of asymptomatic hyperuricemia.
DOSAGE AND ADMINISTRATION:
Febuxostat (Febulas) is recommended at 40 mg or 80 mg once daily.
The recommended starting dose of Febuxostat (Febulas) is 40 mg once daily.
For patients who do not achieve a serum uric acid (SUA) less than 6 mg/dL after 2 weeks with 40 mg, Febulas 80 mg is recommended.
Febuxostat (Febulas)can be administered without regard to food or antacid use.
Limit the dose of (Febulas)to 40 mg once daily in patients with severe renal impairment.